Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

ORCHID PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 27.1336.4218.0322.34159.31

What is the latest EV/Core EBITDA ratio of ORCHID PHARMA ?

The latest EV/Core EBITDA ratio of ORCHID PHARMA is 27.13 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202527.13
Mar202436.42
Mar202318.03
Mar202222.34
Mar2021159.31

How is EV/Core EBITDA of ORCHID PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 27.13
-25.51
Mar2024 36.42
102.00
Mar2023 18.03
-19.29
Mar2022 22.34
-85.98
Mar2021 159.31 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/Core EBITDA ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,369.0 Cr -4.3% -10.2% -51.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,431.0 Cr -0.4% -0.1% -2% Stock Analytics
DIVIS LABORATORIES ₹163,772.0 Cr 0.9% -3% 0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹137,884.0 Cr 2% 1.7% 25.2% Stock Analytics
CIPLA ₹107,503.0 Cr -0.9% -7.2% -9.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,798.0 Cr -0.6% 6.8% 2.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-4.3%

-10.2%

-51.9%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses